Home › Type 1 Diabetes › Ohio › Cincinnati
Type 1 Diabetes clinical trials in Cincinnati, OH
4 studies for Type 1 Diabetes are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
RecruitingPhase 3
- Cincinnati Children's Hospital Medical Center- Site Number : 8400018, Cincinnati
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
RecruitingObservational study
- University of Cincinnati, Cincinnati
Registry for Stage 2 Type 1 Diabetes
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center- Site Number : 8400024, Cincinnati
Effect of C-peptide on Hypoglycemic Counterregulation
RecruitingEarly phase 1Healthy volunteers welcome
- University of Cincinnati, Cincinnati
About Type 1 Diabetes
If the pancreas doesn't make needed insulin, causing blood sugar levels to be too high you have type 1 or juvenile diabetes. Learn the signs.
More about Type 1 Diabetes on MedlinePlus
Type 1 Diabetes trials in other cities
- Aurora, CO26 studies
- Boston, MA21 studies
- Seattle, WA19 studies
- San Francisco, CA16 studies
- Chicago, IL16 studies
- New Haven, CT16 studies
- New York City, NY15 studies
- Indianapolis, IN14 studies
- Miami, FL14 studies
- Atlanta, GA13 studies
- Gainesville, FL13 studies
- Philadelphia, PA11 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)26 studies
- Breast Cancer24 studies
- Heart Failure22 studies
- Metastatic Cancer21 studies
- Colorectal Cancer20 studies
- Obesity20 studies
- Acute Myeloid Leukemia20 studies
- Prostate Cancer19 studies
- Ovarian Cancer18 studies
- Lung Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.